Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses.

Niklas Worm AnderssonEmilia Myrup ThiessonUlrike BaumNicklas PihlströmJostein StarrfeltKristýna FaksováEero PoukkaLars Christian LundChristian Holm HansenMia AakjærJesper KjærCatherine CohetMathijs GoossensMorten AndersenJesper HallasHinta MeijerinkRickard LjungAnders Hviid

Published in: BMJ (Clinical research ed.) (2023)

Heterologous booster schedules are associated with increased protection against severe, omicron related covid-19 outcomes compared with primary course schedules and homologous booster schedules.

Keyphrases

coronavirus disease
sars cov
early onset
dna damage
drug induced
dna repair
type diabetes
metabolic syndrome
weight loss
insulin resistance